8 results
·
29ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: Eu Ivd Class B
×
mAbXmise
Device
EU IVDR
·
Eu Ivd Class B
·Promise proteomics·On the market·9 countries
mAbXmise
Device
EU IVDR
·
Eu Ivd Class B
·Promise proteomics·On the market·9 countries
mAbXmise
Device
EU IVDR
·
Eu Ivd Class B
·Promise proteomics·On the market·9 countries
mAbXmise
Device
EU IVDR
·
Eu Ivd Class B
·Promise proteomics·On the market·9 countries
mAbXmise – Anti-drug antibodies quantification Kit multiplex ANTI-Infliximab & ANTI-Adalimumab
Basic UDI-DI
EU IVDR
·
Eu Ivd Class B
·Promise proteomics·1 device
mAbXmise – Monoclonal antibodies quantification Kit Eculizumab or Ravulizumab
Basic UDI-DI
EU IVDR
·
Eu Ivd Class B
·Promise proteomics·1 device
mAbXmise – Monoclonal antibody quantification Kit Emicizumab
Basic UDI-DI
EU IVDR
·
Eu Ivd Class B
·Promise proteomics·1 device
mAbXmise – Monoclonal antibodies quantification Kit Multiplex Infliximab, Adalimumab, Obinutuzumab, Secukinumab, Tocilizumab, Ustekinumab, Vedolizumab
Basic UDI-DI
EU IVDR
·
Eu Ivd Class B
·Promise proteomics·1 device